Avity Investment Management Inc. increased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 46.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 259,491 shares of the company's stock after purchasing an additional 82,166 shares during the quarter. Procter & Gamble accounts for approximately 3.1% of Avity Investment Management Inc.'s portfolio, making the stock its 11th biggest position. Avity Investment Management Inc.'s holdings in Procter & Gamble were worth $41,342,000 as of its most recent SEC filing.
Other institutional investors also recently bought and sold shares of the company. Nova Wealth Management Inc. acquired a new position in Procter & Gamble in the 1st quarter valued at about $26,000. Capital A Wealth Management LLC acquired a new position in Procter & Gamble in the 4th quarter valued at about $31,000. Quarry LP acquired a new position in Procter & Gamble in the 1st quarter valued at about $33,000. 10Elms LLP acquired a new position in Procter & Gamble in the 4th quarter valued at about $34,000. Finally, Mizuho Securities Co. Ltd. grew its position in Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on PG shares. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Wells Fargo & Company decreased their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. BNP Paribas reiterated an "outperform" rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, UBS Group set a $180.00 price objective on Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $175.12.
View Our Latest Stock Report on Procter & Gamble
Insider Activity at Procter & Gamble
In other Procter & Gamble news, CEO Gary A. Coombe sold 10,194 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jon R. Moeller sold 40,119 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,181 shares of company stock valued at $18,918,012 over the last 90 days. 0.20% of the stock is owned by insiders.
Procter & Gamble Price Performance
PG stock opened at $158.02 on Monday. The business has a 50 day moving average price of $156.21 and a 200 day moving average price of $161.77. The stock has a market cap of $369.85 billion, a price-to-earnings ratio of 24.27, a PEG ratio of 4.17 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were given a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is 64.82%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.